Updated: 4:33 PM EST January 27, 2021
COLUMBUS, Ohio Some might say candy can make you feel better by elevating your mood in certain situations, but scientists are putting it to an even more impactful use.
Researchers at Ohio State University are proposing that using hard candy to look for the loss of taste and smell in populations who are at risk of getting exposed to COVID-19 may help find probable cases of the virus in otherwise asymptomatic people.
The OSU research team got more than $300,000 to fund their study from the National Institutes of Health to figure out easier ways to identify people who have potentially contracted COVID-19.
Public COVID-19 vaccinations for those 80 and older begin at Ohio State It s an exciting day
It was still dark when David Brehm wheeled his mother into the Jerome Schottenstein Center. To her, it felt like the middle of the night. But Helen Formet was wide awake. She was ready. She’d dressed in scarlet, an Ohio State scarf draped around her neck, the university’s Block O logo winding around her walking cane. She wore lipstick under her face mask.
“Smile, Mom!” Brehm shouted over the cameras and microphones.
“I am!” Formet called back.
In fact, she would have leapt for joy if she could. On Jan. 19, just after 7 a.m., 100-year-old Formet became the first member of the public vaccinated at The Ohio State University Wexner Medical Center s mass COVID-19 vaccination site, kicking off a distribution plan that starts with first-round vaccines for those who are 80 and older and rolls out to younger ages in the coming weeks.
E-Mail
IMAGE: Dr. Rama K. Mallampalli is professor and chair of the Department of Internal Medicine at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine. view more
Credit: The Ohio State University Wexner Medical Center
COLUMBUS, Ohio - Research led by The Ohio State University Wexner Medical Center and College of Medicine identified a new compound that might serve as a basis for developing a new class of drugs for diabetes.
Study findings are published online in the journal
Nature Chemical Biology.
The adenosine monophosphate-activated protein kinase (Ampk) is a crucial enzyme involved in sensing the body s energy stores in cells. Impaired energy metabolism is seen in obesity, which is a risk factor for diabetes. Some medications used to treat diabetes, such as metformin, work by increasing the activity of Ampk.
New Report: 36% of Patients Sacrifice Medications to Afford Basic Needs yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Phillip Popovich is a professor and chair of Ohio State s Department of Neuroscience and Executive Director of the Belford Center for Spinal Cord Injury at The Ohio State University College. view more
Credit: The Ohio State University Wexner Medical Center
COLUMBUS, Ohio - Research led by The Ohio State University Wexner Medical Center and College of Medicine found that the widely prescribed pain-relief drug gabapentin can prevent harmful structural changes in the injured spinal cords of mice, and also block cardiovascular changes and immune suppression caused by spinal cord injury. Gabapentin is often prescribed as a treatment for pain, but if it is given early after injury - before symptoms develop - it can also limit structural changes in nerve cells. We show that these benefits remain even one month after stopping gabapentin treatment in spinal injured mice. We believe that gabapentin could be repurposed as a prophylactic therapy that can prevent